Pancreatic
AMG 193 20230223
A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of AMG 193 in Combination With other Therapies in Subjects With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous MTAP-deletion
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Pancreatic cancer
Study Phase
lb
Trial Identifiers
GenesisCare Location(s)
Principal Investigator(s)